02190nam a2200433Ia 4500 271707 271707 ocm55983220 OCoLC 20180706132118.0 he bmb024bbca 040721s2004 dcua bb f000 0 eng d 0160717140 9780160717147 PUCPR eng FPS OCLCQ OCLCO OCLCQ OCLCA OCLCF GPO MvI n-us--- Online 1019-B-01 (MF) Y 4.C 73/8:108-73 Serial no. 108-73 (United States. Congress. House. Committee on Energy and Commerce) Y 4.C 73/8:108-73 United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Prescription drug monitoring : strategies to promote treatment and deter prescription drug use : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, March 4, 2004. Strategies to promote treatment and deter prescription drug use Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. iii, 73 pages : illustrations ; 24 cm text txt rdacontent microform h rdamedia microfiche he rdacarrier "Printed for the use of the Committee on Energy and Commerce." Shipping list no.: 2004-0382-M. "Serial no. 108-73." CRDP Program record. Includes bibliographical references. Microfiche. Washington : Supt. of Docs., U.S. G.P.O., 2004. 1 microfiche : negative. Medication abuse United States Prevention. Medication abuse Law and legislation United States. Online version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Prescription drug monitoring (OCoLC)680494127 Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Prescription drug monitoring (OCoLC)55688393 sudocs 8 0 0 sudocs 0 0 7 7 55 2018-07-06 Federal Depository 0.00 0 Y 4.C 73/8:108-73 Y 4.C 73/8:108 2018-07-06 00:00:00 2018-07-06 8